Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Cai, Read"'
Autor:
Cai Read, Duuamene Nyimanu, Peiran Yang, Rhoda E. Kuc, Thomas L. Williams, Christopher M. Fitzpatrick, Richard Foster, Robert C. Glen, Janet J. Maguire, Anthony P. Davenport
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Signaling through the apelin receptor is beneficial for a number of diseases including pulmonary arterial hypertension. The endogenous small peptides, apelin and elabela/toddler, are downregulated in pulmonary arterial hypertension but are not suitab
Externí odkaz:
https://doaj.org/article/2d0660c081eb47399d2ca55e2ed4196f
Autor:
Edward Stahl, Cullen L. Schmid, Agnes Acevedo‐Canabal, Cai Read, Travis Grim, Nicole M. Kennedy, Thomas D. Bannister, Laura M. Bohn
Publikováno v:
The FASEB Journal. 36
Autor:
Amanda J. Kennedy, Peiran Yang, Cai Read, Rhoda E. Kuc, Lucy Yang, Emily J. A. Taylor, Colin W. Taylor, Janet J. Maguire, Anthony P. Davenport
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 10 (2016)
BackgroundCirculating levels of chemerin are significantly higher in hypertensive patients and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 (CMKLR1 or ChemR23) and is proposed to activate the “orphan” G
Externí odkaz:
https://doaj.org/article/514a9408dd984b9285682713b98ed396
Autor:
Nicole M. Kennedy, Cullen L. Schmid, Agnes Acevedo-Canabal, Edward L. Stahl, Laura M. Bohn, Cai Read, Travis W. Grim, Thomas D. Bannister
Publikováno v:
Proc Natl Acad Sci U S A
The ability of a ligand to preferentially promote engagement of one signaling pathway over another downstream of GPCR activation has been referred to as signaling bias, functional selectivity, and biased agonism. The presentation of ligand bias refle
Autor:
Thomas L Williams, David J. Huggins, Petra Sulentic, Janet J. Maguire, Robyn Macrae, Cai Read, Duuamene Nyimanu, Peiran Yang, Robert C. Glen, Anthony P. Davenport
Publikováno v:
Pharmacological Reviews
The predicted protein encoded by the APJ gene discovered in 1993 was originally classified as a class A G protein-coupled orphan receptor but was subsequently paired with a novel peptide ligand, apelin-36 in 1998. Substantial research identified a fa
Autor:
Robert C. Glen, Anthony P. Davenport, Duuamene Nyimanu, Alexi Crosby, Janet J. Maguire, Guido Buonincontri, Cai Read, Mark Southwood, Thomas L Williams, Nicholas W. Morrell, Peiran Yang, Rhoda E. Kuc, Stephen J. Sawiak
Publikováno v:
British Journal of Pharmacology
© 2019 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. Background and Purpose: Apelin is an endogenous vasodilatory and inotropic peptide that is down-regulated in human p
Autor:
Cai, Read, Duuamene, Nyimanu, Peiran, Yang, Rhoda E, Kuc, Thomas L, Williams, Christopher M, Fitzpatrick, Richard, Foster, Robert C, Glen, Janet J, Maguire, Anthony P, Davenport
Publikováno v:
Frontiers in Pharmacology
Signaling through the apelin receptor is beneficial for a number of diseases including pulmonary arterial hypertension. The endogenous small peptides, apelin and elabela/toddler, are downregulated in pulmonary arterial hypertension but are not suitab
Autor:
Rhoda E. Kuc, Robert C. Glen, Anthony P. Davenport, Thomas L Williams, Peiran Yang, Janet J. Maguire, Andrew Smart, Duuamene Nyimanu, Cai Read, Lucy J. Holt, Haren Arulanantham
The apelin receptor is a potential target in the treatment of heart failure and pulmonary arterial hypertension where levels of endogenous apelin peptides are reduced but significant receptor levels remain. Our aim was to characterise the pharmacolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cae3b8d28cc2ad933db5bb33d968d90b
https://www.repository.cam.ac.uk/handle/1810/290748
https://www.repository.cam.ac.uk/handle/1810/290748
Autor:
Benjamin E, Garfield, Alexi, Crosby, Dongmin, Shao, Peiran, Yang, Cai, Read, Steven, Sawiak, Stephen, Moore, Lisa, Parfitt, Carl, Harries, Martin, Rice, Richard, Paul, Mark L, Ormiston, Nicholas W, Morrell, Michael I, Polkey, Stephen John, Wort, Paul R, Kemp
Publikováno v:
Thorax. 74(2)
Skeletal muscle dysfunction is a clinically important complication of pulmonary arterial hypertension (PAH). Growth/differentiation factor 15 (GDF-15), a prognostic marker in PAH, has been associated with muscle loss in other conditions. We aimed to
Autor:
Amanda J. Kennedy, Cai Read, Rhoda E. Kuc, Peiran Yang, Janet J. Maguire, Anthony P. Davenport
Publikováno v:
Hypertension. 68
Hypertensive patients have significantly higher plasma concentrations of the adipokine chemerin compared with healthy controls, and levels of chemerin positively correlate with systolic and diastolic blood pressure. Chemerin activates chemokine-like